Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Baricitinib shows promise in treating severe hair loss.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Upadacitinib effectively treats severe alopecia areata and is safe.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

The use of Diane-35 and its generics significantly decreased in the Netherlands.